nach oben

Erschienen in:

16.02.2021 | Original Article

Improving dose delivery accuracy with EPID in vivo dosimetry: results from a multicenter study

verfasst von: M. Esposito, Ph. D., A. Piermattei, M. Sc., S. Bresciani, M. Sc., L. C. Orlandini, M. Sc., M. D. Falco, M. Sc., S. Giancaterino, M. Sc., S. Cilla, Ph. D., A. Ianiro, M. Sc., R. Nigro, M. Sc., L. Botez, M. Sc., S. Riccardi, M. Sc., A. Fidanzio, M. Sc., F. Greco, M. Sc., E. Villaggi, M. Sc., S. Russo, M. Sc., M. Stasi, M. Sc., Working Group EPID In Vivo Dosimetry of the Italian Association of Medical Physics AIFM

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate critical aspects and effectiveness of in vivo dosimetry (IVD) tests obtained by an electronic portal imaging device (EPID) in a multicenter and multisystem context.

Materials and methods

Eight centers with three commercial systems—SoftDiso (SD, Best Medical Italy, Chianciano, Italy), Dosimetry Check (DC, Math Resolution, LCC), and PerFRACTION (PF, Sun Nuclear Corporation, SNC, Melbourne, FL)—collected IVD results for a total of 2002 patients and 32,276 tests. Data are summarized for IVD software, radiotherapy technique, and anatomical site. Every center reported the number of patients and tests analyzed, and the percentage of tests outside of the tolerance level (OTL%). OTL% was categorized as being due to incorrect patient setup, incorrect use of immobilization devices, incorrect dose computation, anatomical variations, and unknown causes.

Results

The three systems use different approaches and customized alert indices, based on local protocols. For Volumetric Modulated Arc Therapy (VMAT) treatments OTL% mean values were up to 8.9% for SD, 18.0% for DC, and 16.0% for PF. Errors due to “anatomical variations” for head and neck were up to 9.0% for SD and DC and 8.0% for PF systems, while for abdomen and pelvis/prostate treatments were up to 9%, 17.0%, and 9.0% for SD, DC, and PF, respectively. The comparison among techniques gave 3% for Stereotactic Body Radiation Therapy, 7.0% (range 4.7–8.9%) for VMAT, 10.4% (range 7.0–12.2%) for Intensity Modulated Radiation Therapy, and 13.2% (range 8.8–21.0%) for 3D Conformal Radiation Therapy.

Conclusion

The results obtained with different IVD software and among centers were consistent and showed an acceptable homogeneity. EPID IVD was effective in intercepting important errors.

World Health Organization (2008) Radiotherapy risk profile technical manual. WHO/IER/PSP/2008.12. World Health Organization, Geneva

International Atomic Energy Agency (2013) Development of procedures for in vivo dosimetry in radiotherapy. IAEA Human Health Report No. 8. IAEA, Vienna

McCurdy BM, McCowan PM (2017) In vivo dosimetry for lung radiotherapy including SBRT. Phys Med 44:123–130CrossRef

McCowan PM, Asuni G, Van Uytven E, VanBeek T, McCurdy BM, Loewen SK et al (2017) Clinical implementation of a model-based in vivo dose verification system for stereotactic body radiation therapy–volumetric modulated arc therapy treatments using the electronic portal imaging device. Int J Radiat Oncol Biol Phys 97(5):1077–1084CrossRef

MacDougall ND, Graveling M, Hansen VN, Brownsword K, Morgan A (2017) In vivo dosimetry in UK external beam radiotherapy: current and future usage. J Radiol 90(1072):20160915CrossRef

Mijnheer BJ, González P, Olaciregui-Ruiz I, Rozendaal RA, van Herk M, Mans A (2015) Overview of 3‑year experience with large-scale electronic portal imaging device–based 3‑dimensional transit dosimetry. Pract Radiat Oncol 5(6):e679–e687CrossRef

Piermattei A, Greco F, Grusio MMenna S, Azario L, Stimato G et al (2018) A validation study of a dedicated software for an automated in vivo dosimetry control in radiotherapy. Med Biol Eng Comput 56(10):1939–1947. https://doi.org/10.1007/s11517-018-1822-3CrossRefPubMed

Celi S, Costa E, Wessels Mazal A, Fourquet A, Francois P (2016) EPID based in vivo dosimetry system: clinical experience and results. J Appl Clin Med Phys 17(3):262–276CrossRef

Nailon WH, Welsh D, McDonald K, Burns D, Forsyth J, Cooke G et al (2019) EPID-based in vivo dosimetry using dosimetry check™: overview and clinical experience in a 5-yr study including breast, lung, prostate, and head and neck cancer patients. J Appl Clin Med Phys 20(1):6–16CrossRef

10.

Moustakis C, Tazehmahalleh FE, Elsayad K, Fezeuc F, Scobioalac S (2020) A novel approach to SBRT patient quality assurance using EPID-based real-time transit dosimetry. Strahlenther Onkol 196:182–192CrossRef

11.

Piermattei A, Greco F, Azario L, Porcelli A, Cilla S, Zucca S et al (2012) A national project for in-vivo dosimetry procedures in radiotherapy: first results. Nucl Instrum Methods Phys Res B 274:42–50CrossRef

12.

Jie Li J, Piermattei A, Wang P, Kang S, Xiao M, Tang B et al (2018) Setup in clinical workflow and impact on radiotherapy routine of an in vivo dosimetry procedure with an electronic portal imaging device. PLoS ONE 13(2):e192686. https://doi.org/10.1371/journal.pone.0192686CrossRefPubMed

13.

Falco MD, Giancaterino S, De Nicola A, Adorante N, De Lorenzo RG, Di Tommaso M et al (2018) A feasibility study for in vivo dosimetry procedure in routine clinical practice. Technol Cancer Res Treat 17:1533033818779201. https://doi.org/10.1177/1533033818779201CrossRefPubMedPubMedCentral

14.

Consorti R, Fidanzio A, Brainovich V, Mangiacotti F, De Spirito M, Mirri MA et al (2017) EPID-based in vivo dosimetry for stereotactic body radiotherapy of non-small cell lung tumors: initial clinical experience. Phys Med 42:157–161CrossRef

15.

Cilla S, Ianiro A, Craus M, Viola P, Deodato F, Macchia G et al (2019) Epid-based in vivo dose verification for lung stereotactic treatments delivered with multiple breath-hold segmented volumetric modulated arc therapy. J Appl Clin Med Phys 20(3):37–44CrossRef

16.

Kang S, Li J, Ma J, Zhang W, Liao X, Qing H et al (2019) Evaluation of interfraction setup variations for postmastectomy radiation therapy using EPID-based in vivo dosimetry. Journal of applied clinical medical physics. J Appl Clin Med Phys. https://doi.org/10.1002/acm2.12712CrossRefPubMedPubMedCentral

17.

Renner WD, Sarfaraz M, Earl MA, Yu CX (2003) A dose delivery verification method for conventional and intensity-modulated radiation therapy using measured field fluence distributions. Med Phys 30(11):2996–3005CrossRef

18.

Esposito M, Bastiani P, Ghirelli A, Pini S, Russo S, Zatelli G (2018) Characterization of EPID software for VMAT transit dosimetry. Australas Phys Eng Sci Med 41(4):1021–1027. https://doi.org/10.1007/s13246-018-0693-0CrossRefPubMed

19.

Bresciani S, Poli M, Miranti A, Maggio A, Di Dia A, Bracco C et al (2018) Comparison of two different EPID-based solutions performing pretreatment quality assurance: 2D portal dosimetry versus 3D forward projection method. Phys Med 52:65–71CrossRef

20.

Esposito M, Villaggi E, Bresciani S, Cilla S, Falco MDG et al (2020) Estimating dose delivery accuracy in stereotactic body radiation therapy: a review of in vivo measurement methods. Radiother Oncol 149:158–167. https://doi.org/10.1016/j.radonc.2020.05.014CrossRefPubMed

21.

Olaciregui-Ruiz I, Beddar S, Greer P, Jornet N, McCurdy B, Paiva-Fonseca G et al (2020) In vivo dosimetry in external beam photon radiotherapy: requirements and future directions for research, development, and clinical practice. Phys Imaging Radiat Oncol 15:108–116. https://doi.org/10.1016/j.phro.2020.08.003CrossRefPubMedPubMedCentral

22.

Esposito M, Ghirelli A, Pini S, Alpi P, Barca R, Fondelli S et al (2021) Clinical implementation of 3D in vivo dosimetry for abdominal and pelvic stereotactic treatments. Radiother Oncol 154:14–20. https://doi.org/10.1016/j.radonc.2020.09.011CrossRefPubMed

Titel: Improving dose delivery accuracy with EPID in vivo dosimetry: results from a multicenter study
verfasst von: M. Esposito, Ph. D.
A. Piermattei, M. Sc.
S. Bresciani, M. Sc.
L. C. Orlandini, M. Sc.
M. D. Falco, M. Sc.
S. Giancaterino, M. Sc.
S. Cilla, Ph. D.
A. Ianiro, M. Sc.
R. Nigro, M. Sc.
L. Botez, M. Sc.
S. Riccardi, M. Sc.
A. Fidanzio, M. Sc.
F. Greco, M. Sc.
E. Villaggi, M. Sc.
S. Russo, M. Sc.
M. Stasi, M. Sc.
Working Group EPID In Vivo Dosimetry of the Italian Association of Medical Physics AIFM
Publikationsdatum: 16.02.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Strahlentherapie und Onkologie / Ausgabe 7/2021
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-021-01749-6

Springer Medizin

Improving dose delivery accuracy with EPID in vivo dosimetry: results from a multicenter study